Generic diabetes pill put to the test against Brand-Name drug
NCT ID NCT07266779
First seen Jan 11, 2026 · Last updated May 22, 2026 · Updated 17 times
Summary
This study checked if a generic version of a diabetes pill (Ertugliflozin/Metformin) works the same as the brand-name drug (Segluromet). 36 healthy adults took a single dose of each pill in random order, and researchers measured drug levels in their blood. The goal was to prove the generic is just as effective and safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Veeda Clinical Research Limited
Gujrat, Gujarat, 384205, India
Conditions
Explore the condition pages connected to this study.